CARLA OSTRONIC: Open Payments
NPI 1780774091 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,802 in 192 payments from 44 companies in 2025. Trend: 2023 $3,322 · 2024 $2,956 · 2025 $3,802
Food & beverage: $3,553Education: $249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $888 |
| Novartis Pharmaceuticals Corporation | 18 | $362 |
| E.R. Squibb & Sons, L.L.C. | 20 | $339 |
| Celgene Corporation | 15 | $232 |
| GENZYME CORPORATION | 9 | $170 |
| Merck Sharp & Dohme LLC | 7 | $137 |
| PFIZER INC. | 9 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| ARRAY BIOPHARMA INC | 7 | $104 |
Products named: VENCLEXTA, IMBRUVICA, REBLOZYL, KEYTRUDA, BREYANZI, LUTATHERA, SCEMBLIX, ENHERTU.
Industry payments across MO — which companies pay providers there.
